Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02931175 · ClinicalTrials.gov registry record · Phase 2
ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
A Phase 2 study, sponsored by Quan Dong Nguyen.
- Completed
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT02931175: Completed Phase 2 study, sponsored by Quan Dong Nguyen.
NCT02931175 is a Phase 2 study that has completed, run by Quan Dong Nguyen. The registered enrollment target is 28 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02931175, a Phase 2 study, has completed, sponsored by Quan Dong Nguyen.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
The study aims to evaluate the potential role of ACTH gel in the management of non-infectious uveitis.
Primary Outcome
The incidence and severity of ocular adverse events, as identified by eye examination.
Interventions
- DRUG ACTH gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-11-10 |
| Est. Completion | 2021-10-28 |
| Phase | Phase 2 |
What the finished NCT02931175 record still lists
NCT02931175 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which ACTH gel is the first listed.
NCT02931175 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02931175 about?
NCT02931175 is a clinical study titled "ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)". The study aims to evaluate the potential role of ACTH gel in the management of non-infectious uveitis.
What is the current status of trial NCT02931175?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2017-11-10. Estimated completion is 2021-10-28.
What interventions are being tested in trial NCT02931175?
The interventions under investigation include: ACTH gel (DRUG).
Who is sponsoring clinical trial NCT02931175?
This trial is sponsored by Quan Dong Nguyen, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02931175's enrollment target sits among peer trials
28 1677th of 2000 higher than 304 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI